The value of IDH1, TP53, and TERTp mutations and MGMT and ATRX protein expression level in primary tumours for evaluating the PFS of patients with astrocytic tumours was analysed using the Kaplan-Meier survival estimator. The gene discussed is TP53; the disease is neoplasm.